To keep drug prices high, pharma has been piling up the patents
- ID
- 29490
- Status
- summarized
- Published
- 29 Sep 2026, 3:53 AM
- Fetched
- 29 Sep 2026, 4:59 AM
- Provider
- Ars Technica
- Category
- technology
- Original URL
- https://arstechnica.com/health/2026/09/to-keep-drug-prices-high-pharma-has-been-piling-up-the-patents/
- Source URL
- https://feeds.arstechnica.com/arstechnica/index
Summary
- Score
- 1.0
- Created
- 29 Sep 2026, 5:01 AM
- Tags
- Audience
- developersai_agent_users
What happened
The fetched page contains no article body — only Condé Nast's consent-management boilerplate (the state opt-out list, privacy_administration@condenast.com, 1-877-241-4999, and cookie toggles for Essential/Performance/Audience Measurement cookies). Nothing in the text states how many patents, which drugs, which companies, or what prices changed, so the headline claim about pharma piling up patents cannot be summarized from this source. Treat this item as a failed extraction, not as news.
Why it matters
Do not run this in the segment as a news item — there is no substance to report, and repeating the headline would mean asserting facts the text never gives. The one actionable detail is operational: a URL fetch here returned a consent wall instead of the article, so any scraper or agent pipeline you run should check for boilerplate markers like 'Opt-Out' / 'privacy_administration@condenast.com' before handing text to a summarizer, or you will ship confident summaries of cookie notices.
Discussion angle
Use it as a 3-minute live demo: paste this fetched text into your own summarizer and see whether it invents a pharma story — a quick way to show why extraction validation belongs before the LLM step, not after.